Harvoni Generic India

Harvoni Generic India
Sofosbuvir 400mg and Ledipasvir 90mg

Hetero has received approval form Drug Controller General of India  (DCGI) on 8th Dec-2015 for fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) , 

Ledipasvir +Sofosbuvir  is a two-drug fixed-dose combination product that contains 90 mg of ledipasvir  and 400 mg of  sofosbuvir  in a single tablet, and sold globally by  Gilead Sciences , Inc., under its brand HARVONI ®. It is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.

Natco Ltd ,Hetero Labs  and 5  other company form India had signed a non-exclusive licensing agreement with Gilead Sciences  earlier in 2015, to manufacture and sell generic versions of its chronic hepatitis C medicines, including generic version of  HARVONI ®, in India and other 100 developing countries.

Harvoni Generic India Ledisof & Hepcinat LP

HARVONI ®is a prescription medicine used to treat chronic hepatitis C genotype 1 infection in adults. Click Here for For more information on US FDA Approval

For more infomation on HARVONI ®(Sofosbuvir 400mg and Ledipasvir 90mg) ,Indication and Dosing Please Click Here

Call : +91 8652561080

 This medicine is to be taken strictly under Medical  Supervision  Only